Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?
Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?
Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?
Submitted by
admin
on June 23, 2023 - 10:03am
Source:
Motley Fool
News Tags:
Biogen
Eisai
Alzheimer's disease
FDA
Leqembi
Headline:
Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?
snippet:
The FDA could soon make a decision on Biogen's Alzheimer's drug, Leqembi.
An advisory committee confirmed its clinical benefits, suggesting an approval could be ahead.
The market, however, may already be pricing that prospect into Biogen's richly valued shares.
Do Not Allow Advertisers to Use My Personal information